Atlantis grabs $9.8m in series D:
This article was originally published in Clinica
Executive Summary
Cambridge, Massachusetts-based dental implant developer Atlantis Components has raised $9.8m in a series D financing. The round included the participation of new investor Signet Healthcare Partners as well as its existing shareholders, which include, among others ABV, CID Equity Capital and Ironwood Equity Fund. Proceeds from the financing will go towards expanding Atlantis' market presence. The company produces patient-specific dental implants using 3D digital imaging and integrated manufacturing methods.
You may also be interested in...
10 Predictions On How Health Policy Could Change Under A Biden Presidency
Health policy changes that President-elect Joe Biden will likely make during his four-year term include Medicaid expansion and a greater reliance on medical science, among others, experts say.
Hologic Aptima Assay Cleared For HIV Detection
Already cleared to monitor the viral load in HIV-positive individuals, the test has now been approved for initial diagnosis as well.
Alnylam Turns To Value-Based Pricing Again For Oxlumo
As with its first two approved RNAi therapies, Alnylam will negotiate value-based agreements with payers, but for Oxlumo, approved in pediatric patients, it will offer a patient need adjustment.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: